↓ Skip to main content

Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when co-administered with combined oral contraceptives.

Overview of attention for article published in JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
2 policy sources
twitter
2 tweeters

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when co-administered with combined oral contraceptives.
Published in
JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 2012
DOI 10.1097/qai.0b013e31827e8f98
Pubmed ID
Authors

Landolt NK, Phanuphak N, Ubolyam S, Pinyakorn S, Kriengsinyot R, Ahluwalia J, Thongpaeng P, Gorowara M, Thammajaruk N, Chaithongwongwatthana S, Lange JM, Ananworanich J, Nadia Kancheva Landolt, Nittaya Phanuphak, Sasiwimol Ubolyam, Suteeraporn Pinyakorn, Rosalin Kriengsinyot, Jennisa Ahluwalia, Parawee Thongpaeng, Meena Gorowara, Narukjaporn Thammajaruk, Surasith Chaithongwongwatthana, Joep M. A. Lange, Jintanat Ananworanich

Abstract

Effective contraception has been widely promoted for HIV-positive women. However, there are limited data on the interactions between combined hormonal contraceptives and nonnucleoside reverse transcriptase inhibitors .

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 4%
Unknown 25 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Student > Master 4 15%
Student > Ph. D. Student 4 15%
Student > Doctoral Student 3 12%
Student > Bachelor 2 8%
Other 8 31%
Readers by discipline Count As %
Medicine and Dentistry 14 54%
Business, Management and Accounting 2 8%
Agricultural and Biological Sciences 2 8%
Biochemistry, Genetics and Molecular Biology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Other 4 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2016.
All research outputs
#1,254,623
of 8,148,366 outputs
Outputs from JAIDS: Journal of Acquired Immune Deficiency Syndromes
#284
of 2,448 outputs
Outputs of similar age
#52,396
of 293,947 outputs
Outputs of similar age from JAIDS: Journal of Acquired Immune Deficiency Syndromes
#9
of 68 outputs
Altmetric has tracked 8,148,366 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,448 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,947 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.